Fill Out Your Profile to share more about you. Learn more...
Take Our Poll: What’s most important to you for your overall health?
Promising New Treatment for Metastatic Breast Cancer
Options
moderators
Posts: 8,067
Promising New Treatment for Metastatic Breast Cancer
Nov 2, 2023
Dr. Aditya Bardia discusses encouraging results from a study on a new medicine for hormone receptor-positive, HER2-negative breast cancer.
At the European Society for Medical Oncology (ESMO) 2023 Congress Aditya Bardia, MD, MPH, presented results from the TROPION-Breast01 trial, which is comparing a new antibody-drug conjugate, datopotamab-deruxtecan (dato-DXd), to doctors’ choice of chemotherapy for inoperable or metastatic, hormone receptor-positive, HER2-negative breast cancer that had grown while being treated with hormonal therapy and also had been treated with chemotherapy.
Listen to the podcast to hear Dr. Bardia explain:
- what an antibody-drug conjugate is
- the design of the TROPION-Breast01 study and the first results
- dato-DXd side effects
- how dato-DXd might fit into the current treatment landscape for metastatic breast cancer
2
Categories
Join Us on Zoom: Upcoming virtual meetups. Read more...
Give your account some personality! Add a profile photo.